ATE136551T1 - Festphase-verfahren zur gewinnung von thymosin- alpha-1 - Google Patents

Festphase-verfahren zur gewinnung von thymosin- alpha-1

Info

Publication number
ATE136551T1
ATE136551T1 AT89304584T AT89304584T ATE136551T1 AT E136551 T1 ATE136551 T1 AT E136551T1 AT 89304584 T AT89304584 T AT 89304584T AT 89304584 T AT89304584 T AT 89304584T AT E136551 T1 ATE136551 T1 AT E136551T1
Authority
AT
Austria
Prior art keywords
alpha
moz
amino acids
trifluoroacetic acid
groups
Prior art date
Application number
AT89304584T
Other languages
English (en)
Inventor
Su Sun Wang
Original Assignee
Alpha 1 Biomedicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha 1 Biomedicals Inc filed Critical Alpha 1 Biomedicals Inc
Application granted granted Critical
Publication of ATE136551T1 publication Critical patent/ATE136551T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/063General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha-amino functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57581Thymosin; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89304584T 1988-05-10 1989-05-05 Festphase-verfahren zur gewinnung von thymosin- alpha-1 ATE136551T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19234988A 1988-05-10 1988-05-10

Publications (1)

Publication Number Publication Date
ATE136551T1 true ATE136551T1 (de) 1996-04-15

Family

ID=22709272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89304584T ATE136551T1 (de) 1988-05-10 1989-05-05 Festphase-verfahren zur gewinnung von thymosin- alpha-1

Country Status (7)

Country Link
US (2) US5610272A (de)
EP (1) EP0341935B1 (de)
JP (1) JP2812709B2 (de)
KR (1) KR970010922B1 (de)
AT (1) ATE136551T1 (de)
DE (1) DE68926178T2 (de)
HK (1) HK1014627A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68926178T2 (de) * 1988-05-10 1996-11-28 Alpha 1 Biomedicals Inc Festphase-Verfahren zur Gewinnung von Thymosin-alpha-1
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US6921751B1 (en) * 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US20040202645A1 (en) * 2003-04-08 2004-10-14 Khan Nisar Ahmed Administration of gene-regulatory peptides
EP1300418A1 (de) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US20050037430A1 (en) * 2000-03-29 2005-02-17 Biotempt B.V. Methods and uses for protein breakdown products
US20050020495A1 (en) * 2001-10-24 2005-01-27 Martins Eduardo Bruno Guimaraes Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
DE602006008781D1 (de) * 2005-05-04 2009-10-08 Lonza Ag Festphasengebundenes thymosin-alpha1 und dessen synthese
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー.フェー. 腫瘍の治療
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
ES2288118B1 (es) 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
CA2677948C (en) * 2007-02-12 2014-12-09 Biotempt B.V. Treatment of trauma-hemorrhage with short oligopeptides
US20080217002A1 (en) * 2007-03-07 2008-09-11 Floyd Randolph Simonds Sand control screen having a micro-perforated filtration layer
CN101104638B (zh) * 2007-06-18 2011-06-01 苏州天马医药集团天吉生物制药有限公司 胸腺素α1的固相合成工艺
CN103980357B (zh) * 2013-09-10 2017-07-07 杭州阿诺生物医药科技股份有限公司 一种合成胸腺法新的方法
CN108218980B (zh) * 2016-12-21 2020-12-08 鲁南制药集团股份有限公司 一种胸腺法新的合成方法
CN109748954B (zh) * 2017-11-06 2022-03-01 正大天晴药业集团股份有限公司 一种地加瑞克的纯化方法
WO2022196797A1 (ja) 2021-03-19 2022-09-22 富士フイルム株式会社 アミノ酸又はペプチドの製造方法、保護基形成用試薬、及び、化合物
CN116159514B (zh) * 2023-01-17 2026-01-02 希施生物科技(上海)有限公司 裂解喷雾沉淀冷凝系统及除去三氟乙酸的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207311A (en) * 1977-07-18 1980-06-10 The Salk Institute For Biological Studies Peptides having analgesic and thermoregulative properties
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
JPS54148722A (en) * 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4244946A (en) * 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4382922A (en) * 1980-08-29 1983-05-10 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4361673A (en) * 1980-09-19 1982-11-30 American Home Products Corporation Polypeptide compositions
US4406832A (en) * 1981-09-03 1983-09-27 Mallinckrodt, Inc. Peptide-type substrates useful in the quantitative determination of endotoxin
US4507230A (en) * 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use
US4855407A (en) * 1985-04-11 1989-08-08 Alpha-1 Biomedicals, Inc. Solid phase process for synthesizing peptides
DE68926178T2 (de) * 1988-05-10 1996-11-28 Alpha 1 Biomedicals Inc Festphase-Verfahren zur Gewinnung von Thymosin-alpha-1

Also Published As

Publication number Publication date
DE68926178D1 (de) 1996-05-15
JPH0236197A (ja) 1990-02-06
EP0341935A2 (de) 1989-11-15
HK1014627A1 (en) 1999-09-30
US5610272A (en) 1997-03-11
DE68926178T2 (de) 1996-11-28
KR970010922B1 (ko) 1997-07-02
EP0341935B1 (de) 1996-04-10
KR890017267A (ko) 1989-12-15
EP0341935A3 (de) 1991-05-22
JP2812709B2 (ja) 1998-10-22
US5856440A (en) 1999-01-05

Similar Documents

Publication Publication Date Title
ATE136551T1 (de) Festphase-verfahren zur gewinnung von thymosin- alpha-1
Yajima et al. Trifluoromethanesulphonic acid, as a deprotecting reagent in peptide chemistry
NISHIUCHI et al. Synthesis of γ‐carboxyglutamic acid‐containing peptides by the Boc strategy
RU94005001A (ru) Лиофилизат на основе пептида
JP2733591B2 (ja) 固相ペプチド合成法
EP0073829A1 (de) Schnelle quantitative herstellung von peptiden unter verwendung von mischanhydriden.
SU1423000A3 (ru) Способ получени пептидов
KISO et al. Efficient solid phase peptide synthesis: Use of methanesulfonic acid α‐amino deprotecting procedure and new coupling reagent, 2‐(benzotriazol‐1‐yl) oxy‐1, 3‐dimethylimidazolidinium hexafluorophosphate (BOI)
DK162130C (da) Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider
DE69121742D1 (de) Verfahren zur Herstellung von Somatotropinmonomeren in reiner Form
Schwartz et al. Synthesis of des (tetrapeptide B1-4) and des (pentapeptide B1-5) human insulin. Two biologically active analogs
FR2605315B1 (fr) Procede de preparation de trifluoroacetate d'ethyle.
KISO et al. Efficient solid phase peptide synthesis on a phenacyl-resin by a methanesulfonic acid α-amino deprotecting procedure
STEWART Protection of the hydroxyl group in peptide synthesis
Kiso et al. A FLUORIDE ION DEPROTECTION STRATEGY IN PEPTIDE SYNTHESIS. COMBINATION WITH SELECTIVE DEPROTECTION USING THE DILUTE METHANESULFONIC ACID OF α-AMINO PROTECTING GROUPS
Kimura et al. Solution synthesis of [ASN76]-human parathyroid hormone (1-84)
US6448031B1 (en) Process for producing LH-RH derivatives
US4579841A (en) Dipeptide derivatives having opiate activity
Kurano et al. Total synthesis of porcine cholecystokinin-33 (CCK-33)
Fauchere et al. Differential protection and selective deprotection in peptide synthesis
RU2091389C1 (ru) Пептид, обладающий иммуномодулирующей активностью
Heavner et al. Cleavage of peptides from benzhydrylamine resins using trifluoromethanesulfonic acid
Sano et al. Side reactions of hydrogen fluoride on peptides containing glutamic acid in or near the C-terminus in solid phase synthesis
JP2777193B2 (ja) ペプチドの製造方法
Acher Chemistry of neurohypophysial hormones

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties